Hyaluronidase / trastuzumab User Reviews & Ratings
Brand names: Herceptin Hylecta
Hyaluronidase / trastuzumab has an average rating of 10.0 out of 10 from a total of 1 reviews on Drugs.com. 100% of reviewers reported a positive experience, while 0% reported a negative experience.
| Condition | Avg. Rating | Reviews | Compare |
|---|---|---|---|
| Breast Cancer | 1 reviews for Breast Cancer | 83 medications |
See also:
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Arimidex
Arimidex is used to treat breast cancer in postmenopausal women. Learn about side effects ...
Femara
Femara lowers estrogen levels and is used to treat breast cancer in postmenopausal women. Learn ...
Ibrance
Ibrance is used to treat HR-positive, HER2-negative breast cancer in postmenopausal women or men ...
Xeloda
Xeloda is used to treat breast and colorectal cancers. Learn about side effects, interactions and ...
Are you taking this medicine?
Your review helps others make informed decisions.More about hyaluronidase / trastuzumab
- Check interactions
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: HER2 inhibitors
- En español
Patient resources
- Hyaluronidase and trastuzumab drug information
- Trastuzumab and hyaluronidase-oysk (Advanced Reading)
For Breast Cancer "Switched to this form of Herceptin from a 30-minute infusion by port. I continue to get clean PET scans. Much shorter treatment time-the SQ injection only takes 6-10 minutes, and there is no after discomfort. Much less stress to be in and out of infusion in less than one hour."